Israel Desks

Israeli health tech thrives amid global challenges, attracting USD1.2 billion in 2024

Idan Nishlis — Thu, 16 Jan 2025 17:08:18 +0000

The Health Tech Top 100 map, compiled by Startup Nation Central’s Finder platform, underscores Israel’s key role in biopharma, digital health, and medical devices.

While total funding decreased slightly from USD1.6 billion in 2023, the sector saw a notable increase in the average deal size, which reached USD4.6 million across 102 funding rounds—more than double the previous year’s median of USD2.16 million.

USD41B in exits: Why Israeli cyber startups are a global powerhouse

Idan Nishlis — Thu, 16 Jan 2025 17:04:23 +0000

Israeli cybersecurity startups have achieved significant success, generating USD41 billion in exits through mergers, acquisitions, and IPOs over the past six years, including USD4.5 billion from cyber M&As in the past year alone.

Israeli tech flotations seen reviving in 2025

Idan Nishlis — Thu, 16 Jan 2025 17:01:52 +0000

A new survey by Poalim Tech and research company Meidata strengthens the forecast that 2025 will be a turnaround year.

The survey, conducted among dozens of venture capital investors and leading investment banks, finds that at least five Israeli companies are expected to make IPOs in the coming year.

“The most strategic country in the world” – Singapore is doubling down on Israeli tech

Idan Nishlis — Thu, 16 Jan 2025 16:58:01 +0000

Singapore has emerged as an extremely attractive market for Israeli entrepreneurs in recent years, as tech relations between the two nations grow.

Ambassador Ian Mak tells CTech that “the impetus for technological cooperation is greater than ever,” as the island state increases its investment in Israel’s tech ecosystem, offering robust support to attract Israeli business and foster cross-border collaboration in areas like cybersecurity, AI, and fintech.

Quantum Machines raising USD100m amid global quantum race

Idan Nishlis — Thu, 16 Jan 2025 16:41:02 +0000

Quantum Machines, an Israeli startup specializing in control systems for quantum computers, has secured USD 100 million in its latest funding round, marking the largest investment in Israel’s quantum technology sector to date.

This substantial capital infusion reflects growing confidence in Quantum Machines’ innovative approach to quantum computing.

Learn more in Calcalist.

The post Quantum Machines raising USD100m amid global quantum race appeared first on Israel Desks.

Court halves patent cost award in Eli Lilly case

Idan Nishlis — Thu, 16 Jan 2025 16:29:54 +0000

The Jerusalem District Court has significantly reduced a cost award in a patent opposition appeal involving Eli Lilly and Teva.

Eli Lilly’s patent application for the osteoporosis drug Forteo faced opposition from Teva, with the Israeli Patent Registrar ruling in Teva’s favour and awarding legal costs of NIS 1.8 million.

On appeal, the Court reduced these costs by nearly 50% to NIS 1 million, deeming the initial amount excessively high.

This decision marks a rare instance of appellate intervention in cost rulings, sending a strong signal to the Patent Office to align cost awards with norms applied by Israeli courts. The ruling establishes a key precedent, ensuring greater fairness in patent proceedings and balancing the financial risks for litigants.

Eli Lilly was represented by Patent Attorney Dr. Kfir Luzzatto, Attorney Oren Mandler, and Patent Attorney Dr. Adina Cohen.

The outcome not only represents a significant victory for Eli Lilly but also sets a standard likely to influence future cases within the intellectual property landscape.

The post Court halves patent cost award in Eli Lilly case appeared first on Israel Desks.

BioLineRx Raises USD 10m in offering

Idan Nishlis — Thu, 16 Jan 2025 16:10:49 +0000

BioLineRx Ltd., a clinical-stage biopharmaceutical company specialising in oncology, has completed a USD 10 million registered direct offering. The Israel-based firm is dedicated to developing innovative treatments to improve outcomes for cancer patients.

The offering underscores investor confidence in BioLineRx’s groundbreaking pipeline of oncology therapies. The proceeds will support ongoing clinical development and advance its mission to deliver transformative solutions in cancer care.

Greenberg Traurig’s Tel Aviv team, led by Capital Markets shareholder Gary Emmanuel, with support from attorneyMichael Soumas, represented BioLineRx in this pivotal transaction.

The post BioLineRx Raises USD 10m in offering appeared first on Israel Desks.

ARBE raises up to USD49m

Idan Nishlis — Thu, 16 Jan 2025 16:07:54 +0000

Arbe Robotics Ltd., a pioneer in 4D imaging radar technology for autonomous vehicles, has successfully completed a public offering on NASDAQ, raising up to USD 49 million.
The transaction includes an initial capital infusion of USD 15 million, with an additional USD 34 million contingent upon the exercise of associated warrants.

The funds will propel Arbe’s development and production of high-resolution radar chipsets, enhancing safety and performance in autonomous driving systems. This achievement underscores investor confidence in Arbe’s innovative solutions and its potential to lead the automotive radar market.

Arbe Robotics was represented by Ellenoff Grossman & Schole, with Erdinast, Ben Nathan, Toledano’s acting as Israeli counsel, with a legal team, comprising partners Shay Dayan and Lior Etgar, together with attorneys Bar Fenster and Shmaryahu Green.

Mintz represented the underwriters.

The post ARBE raises up to USD49m appeared first on Israel Desks.

The Ashstrom Group raises NIS 600m

Idan Nishlis — Thu, 16 Jan 2025 15:59:37 +0000

Ashtrom Group, a prominent Israeli real estate company, has successfully raised NIS 600 million through a public offering of shares, attracting demand of approximately NIS 750 million.

Institutional investors, including Clal Insurance and Harel, participated prominently, with controlling shareholders—the Nussbaum and Giron families via Yundco—investing NIS 100 million. This participation will dilute their holdings from 57% to just under 54%.

The offering reflects strong institutional confidence in Ashtrom despite recent challenges, including the war’s impact on the construction sector.

Firon Law Firm represented Ashtrom in this transaction, with legal counsel provided by Vice Chairman Udi Efron, Adv. Moshe Leshem, and Adv. Yuval Kleinfeld-Yehezkel.

The post The Ashstrom Group raises NIS 600m appeared first on Israel Desks.

Albar raises NIS 582m in bonds

Idan Nishlis — Thu, 16 Jan 2025 15:54:18 +0000

Albar Mimunit Services Ltd. has successfully completed a public offering of two new bond series, raising NIS 582 million. The offering highlights Albar’s strong position in the market and its ability to attract significant investor interest.

The funds raised will support Albar’s ongoing operations and growth initiatives, further solidifying its presence in the financial and leasing sectors.

Goldfarb Gross Seligman, represented Albar in this significant transaction.

The post Albar raises NIS 582m in bonds appeared first on Israel Desks.